| WKN: | A1X3W0 | 
| ISIN: | DE000A1X3W00 | 
| Land: | Deutschland | 
| Branche: | Chemie, Pharma, Bio- & Medizintechnik | 
| Sektor: | Biotechnologie | 
Weshalb die Medigene-Aktie
                                                ein D-Rating hat,
                                                erfahren Sie im Performance-Check
                                                vom 04. November 2025 Info.
| GD 20 | GD 38 | GD 50 | GD 100 | GD 200 | |
|---|---|---|---|---|---|
| Medigene | |||||
| TecDax | |||||
| MDax | |||||
| Dax | |||||
| BCDI Deutschland | |||||
| BCDI | |||||
| BCDI USA | |||||
| Euro Stoxx 50 | |||||
| Dow Jones | |||||
| Nasdaq 100 | |||||
| S&P 500 | 
| GD 20 | GD 38 | GD 50 | GD 100 | GD 200 | |
|---|---|---|---|---|---|
| Medigene | |||||
| Abbvie | |||||
| Amgen | |||||
| Bio-Techne | |||||
| Biogen | |||||
| Eurofins Scientific | |||||
| Genmab | |||||
| Gilead Sciences | |||||
| IDEXX Laboratories | |||||
| Moderna | |||||
| Novonesis | |||||
| Regeneron Pharmaceuticals | |||||
| Sartorius Stedim Biotech | |||||
| Swedish Orphan Biovi | |||||
| UCB |